Temporal trends in the epidemiology of hip osteoarthritis in the USA, 1990-2019: a cross-sectional time-series study using GBD data

美国1990-2019年髋关节骨关节炎流行病学的时间趋势:一项基于全球疾病负担数据的横断面时间序列研究

阅读:1

Abstract

OBJECTIVES: To evaluate temporal trends in the epidemiology of hip osteoarthritis (OA) in the USA from 1990 to 2019, with stratification by sex and geographic region. DESIGN: Cross-sectional time-series analysis using secondary data from the Global Burden of Disease (GBD) study. SETTING: US population-based analysis, stratified by the four US Census Bureau regions: Northeast, Midwest, South and West. PARTICIPANTS: De-identified, aggregate population-level data representing all adults in the USA from 1990 to 2019, drawn from the GBD database. PRIMARY AND SECONDARY OUTCOME MEASURES: Age-standardised rates per 100 000 population for years lived with disability (YLDs), prevalence and incidence of hip OA. Outcomes were stratified by sex and region. Statistical significance was defined as p<0.05. RESULTS: Between 1990 and 2019, hip OA in the USA increased by 23.91% in YLDs, 24.67% in prevalence and 25.22% in incidence. In 2019, the mean YLDs were 28.30 in women versus 25.48 in men; prevalence was 49.55 versus 41.08; and incidence was 919.29 versus 818.10 (all p<0.001). Regionally, the Northeast had the highest mean YLDs (30.1), prevalence (52.4) and incidence (950.5), while the South had the lowest (YLDs: 24.5, prevalence: 40.7, incidence: 805.2). These sex-based and region-based disparities were statistically significant (p<0.05). CONCLUSIONS: There has been a substantial rise in the burden of hip OA in the USA over the past three decades. Women and residents of the Northeastern USA are disproportionately affected. These findings underscore the need for targeted public health strategies that account for geographic and sex-based disparities in hip OA burden.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。